Patent · US Active

Method for inhibiting “melanoma inhibitory activity” MIA

US8148493B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

Antisense Pharma GmbH · DE

Inventors

Anja-Katrin Bosserhoff · Regensburg, DE
Reinhard Buettner · Bonn, DE
Mara Szyrach · Rottenburg am Neckar, DE
Guenter Auerbach · Lappersdorf, DE
Piotr Jachimczak · Würzburg, DE
Karl-Hermann Schlingensiepen · Bovenden, DE

Key dates

Filing date	Oct 21, 2008
Grant date	Apr 3, 2012
Priority date	—
Expiry date	Jun 27, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to peptides, antibodies and antibody fragments inhibiting activity of “Melanoma Inhibitory Activity” (MIA).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.